vs
Side-by-side financial comparison of Invivyd, Inc. (IVVD) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $13.3M, roughly 1.3× Laird Superfood, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -64.3%, a 51.2% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 15.0%).
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
IVVD vs LSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.2M | $13.3M |
| Net Profit | $-11.1M | $-1.8M |
| Gross Margin | — | 34.1% |
| Operating Margin | -73.0% | -13.5% |
| Net Margin | -64.3% | -13.2% |
| Revenue YoY | 24.5% | 15.0% |
| Net Profit YoY | 40.0% | -341.4% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.2M | $13.3M | ||
| Q3 25 | $13.1M | $12.9M | ||
| Q2 25 | $11.8M | $12.0M | ||
| Q1 25 | $11.3M | $11.7M | ||
| Q4 24 | $13.8M | $11.6M | ||
| Q3 24 | $9.3M | $11.8M | ||
| Q2 24 | $2.3M | $10.0M | ||
| Q1 24 | $0 | $9.9M |
| Q4 25 | $-11.1M | $-1.8M | ||
| Q3 25 | $-10.5M | $-975.1K | ||
| Q2 25 | $-14.7M | $-362.2K | ||
| Q1 25 | $-16.3M | $-156.2K | ||
| Q4 24 | $-18.4M | $-398.4K | ||
| Q3 24 | $-60.7M | $-166.1K | ||
| Q2 24 | $-47.2M | $-239.1K | ||
| Q1 24 | $-43.5M | $-1.0M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
| Q4 25 | -73.0% | -13.5% | ||
| Q3 25 | -84.0% | -7.7% | ||
| Q2 25 | -127.8% | -3.3% | ||
| Q1 25 | -149.7% | -1.9% | ||
| Q4 24 | -139.1% | -4.1% | ||
| Q3 24 | -670.0% | -2.3% | ||
| Q2 24 | -2175.2% | -3.4% | ||
| Q1 24 | — | -11.0% |
| Q4 25 | -64.3% | -13.2% | ||
| Q3 25 | -79.7% | -7.6% | ||
| Q2 25 | -124.4% | -3.0% | ||
| Q1 25 | -144.1% | -1.3% | ||
| Q4 24 | -133.5% | -3.4% | ||
| Q3 24 | -653.1% | -1.4% | ||
| Q2 24 | -2086.9% | -2.4% | ||
| Q1 24 | — | -10.3% |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $-0.06 | — | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.51 | — | ||
| Q2 24 | $-0.40 | — | ||
| Q1 24 | $-0.38 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $226.7M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $241.5M | $11.5M |
| Total Assets | $276.9M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $226.7M | $5.1M | ||
| Q3 25 | $85.0M | $5.1M | ||
| Q2 25 | $34.9M | $3.9M | ||
| Q1 25 | $48.1M | $7.0M | ||
| Q4 24 | $69.3M | $8.3M | ||
| Q3 24 | $106.9M | $7.9M | ||
| Q2 24 | $147.9M | $7.6M | ||
| Q1 24 | $189.4M | $7.1M |
| Q4 25 | $241.5M | $11.5M | ||
| Q3 25 | $93.1M | $12.8M | ||
| Q2 25 | $42.8M | $13.4M | ||
| Q1 25 | $54.1M | $13.3M | ||
| Q4 24 | $67.5M | $13.2M | ||
| Q3 24 | $83.2M | $13.1M | ||
| Q2 24 | $140.6M | $12.6M | ||
| Q1 24 | $178.5M | $12.7M |
| Q4 25 | $276.9M | $19.2M | ||
| Q3 25 | $139.2M | $18.9M | ||
| Q2 25 | $89.1M | $20.4M | ||
| Q1 25 | $103.7M | $21.5M | ||
| Q4 24 | $129.5M | $19.3M | ||
| Q3 24 | $161.9M | $18.8M | ||
| Q2 24 | $177.3M | $18.0M | ||
| Q1 24 | $215.5M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.5M | $68.4K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.5M | $68.4K | ||
| Q3 25 | $-8.3M | $1.2M | ||
| Q2 25 | $-13.3M | $-2.8M | ||
| Q1 25 | $-21.1M | $-1.3M | ||
| Q4 24 | $-37.6M | $339.2K | ||
| Q3 24 | $-41.1M | $305.8K | ||
| Q2 24 | $-41.6M | $642.7K | ||
| Q1 24 | $-50.2M | $-422.3K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-13.3M | — | ||
| Q1 25 | $-21.3M | — | ||
| Q4 24 | $-37.6M | — | ||
| Q3 24 | $-41.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-50.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -112.9% | — | ||
| Q1 25 | -188.2% | — | ||
| Q4 24 | -272.2% | — | ||
| Q3 24 | -441.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IVVD
Segment breakdown not available.
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
